EASL has published several reports on liver disease in Europe and is commissioning work on future publications.
Prevalence of NAFLD continues to rise and is now becoming one of the most frequent causes of cirrhosis (advanced liver disease) and liver transplantation in Europe
Full version of Policy Statement
Risk Factors and the Burden of Liver Disease in Europe and Selected Central Asian Countries. The aims of this latest report were to report on the latest epidemiological burd-en of liver disease in the wider European region, to present the data on the main risk factors for liver disease
and to carry out a review of reviews on public health interventions.
See here the HEPAHEALTH Report Epidemiological and Risk Factors data
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease. As a result, worldwide there are approximately 71 million chronically infected individuals. Clinical care for patients with HCV-related liver disease is advancing considerably. Most importantly thanks to an enhanced understanding of the pathophysiology of the disease. And also because of developments in diagnostic procedures and improvements in therapy and prevention. EASL Recommendations on Treatment of Hepatitis C describe the optimal management of patients with acute and chronic HCV infections in 2018 and onwards.
Read More
HEPAMAP, a roadmap for Liver Disease Research in Europe (2014) identifies the major research gaps at European level in liver disease
Read More
EASL has published two reports on liver disease in Europe. The Burden of Liver Disease (2013) provides useful facts and figures on the prevalence and causes of numerous liver diseases across the region.
Read More